Scientists at the Scripps Clinic in California have started research on an autologous stem-cell therapy for Parkinson’s disease intended to help patients produce sufficient amounts of dopamine to alleviate the worst symptoms of the disorder. ---Subscribe to MedNous to access this article--- Regenerative Medicine
